New Bone-Boosting shot tested for first time in humans
Disease control
ENROLLING_BY_INVITATION
This early-stage study tests a new injectable drug called LYN101 in 44 people. First, healthy volunteers get a single dose to check safety. Then, postmenopausal women with low bone mass get multiple doses to see how the drug affects bone turnover markers. The main goal is safety,…
Phase: PHASE1 • Sponsor: Shanghai TTM-Bio Technology Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC